bf/NASDAQ:AYTU_icon.png

NASDAQ:AYTU

Aytu BioPharma, Inc.

  • Stock

USD

Last Close

2.14

06/11 21:00

Market Cap

16.90M

Beta: −0.41

Volume Today

70.27K

Avg: 68.94K

PE Ratio

−0.52

PFCF: 3.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
Jun '25
average inventory
19.72K
-
282.07K
1,330.33%
918.46K
225.61%
1.33M
44.33%
1.39M
4.82%
5.72M
311.64%
13.17M
130.24%
13.59M
3.23%
11.42M
15.98%
12.31M
7.81%
12.03M
2.28%
average payables
923.16K
-
2.36M
155.46%
2.87M
21.70%
2.17M
24.39%
2.21M
1.77%
7.06M
219.72%
15.54M
120.08%
15.12M
2.69%
12.23M
19.10%
11.96M
2.24%
10.52M
12.03%
average receivables
78.53K
-
159.74K
103.42%
345.23K
116.12%
553.41K
60.30%
1.16M
109.57%
3.46M
198.19%
16.68M
382.19%
24.94M
49.58%
25.32M
1.53%
26.28M
3.76%
27.39M
4.22%
book value per share
1.12M
-
219.24K
80.34%
19.42K
91.14%
4.03K
79.22%
181.87
95.49%
420.50
131.21%
164.29
60.93%
31.36
80.91%
11.79
62.39%
5.00
57.58%
3.02
39.63%
capex per share
-48.98K
-
-541.79
98.89%
-22.45
95.86%
-1.54
93.16%
0.04
-
capex to depreciation
-2.58
-
-0.03
99.01%
-0.03
12.75%
-0.02
23.88%
0.04
-
capex to operating cash flow
0.21
-
0.01
96.18%
0.00
41.93%
0.00
7.67%
-0.12
-
capex to revenue
-0.88
-
-0.03
96.06%
-0.02
41.08%
-0.01
59.95%
0.00
-
cash per share
525.22K
-
197.73K
62.35%
3.89K
98.03%
2.11K
45.90%
283.39
86.55%
212.79
24.91%
59.29
72.13%
13.17
77.79%
6.89
47.70%
3.61
47.58%
4.93
36.49%
days of inventory on hand
163.39
-
200.11
22.47%
337.93
68.87%
238.34
29.47%
238.70
0.15%
483.22
102.44%
163.69
66.12%
89.21
45.50%
107.40
20.38%
174.56
62.54%
203.08
16.34%
days payables outstanding
4.96K
-
1.34K
72.93%
571.80
57.40%
377.30
34.01%
380.78
0.92%
571.42
50.06%
192.91
66.24%
90.35
53.16%
120.67
33.56%
144.25
19.54%
188.28
30.52%
days sales outstanding
218.98
-
23.14
89.43%
59.83
158.58%
57.72
3.52%
86.80
50.38%
68.37
21.23%
156.70
129.19%
81.98
47.68%
98.34
19.96%
106.42
8.21%
171.31
60.97%
debt to assets
0.01
-
0.11
712.16%
0.13
23.86%
0.12
9.28%
0.13
6.85%
0.01
88.33%
debt to equity
0.02
-
0.21
875.06%
0.39
91.51%
0.42
5.35%
0.55
31.31%
0.10
82.06%
dividend yield
earnings yield
-1.51
-
-1.64
8.20%
-2.31
41.48%
-2.94
27.15%
-3.15
7.07%
-0.06
98.17%
-0.69
1,105.08%
-5.43
681.80%
-3.19
41.20%
-1.00
68.59%
-0.99
1.25%
enterprise value
-2.25M
-
9.17M
508.23%
8.92M
2.70%
-3.55M
139.81%
3.92M
210.41%
18.10M
361.58%
62.60M
245.87%
19.11M
69.47%
-1.29M
106.72%
10.91M
949.09%
-15.41M
241.18%
enterprise value over ebitda
0.30
-
-0.69
330.12%
-0.62
10.52%
0.40
164.30%
-0.90
326.76%
-0.74
18.04%
-4.32
487.40%
0.46
110.72%
0.17
63.47%
1.83
984.09%
1.97
7.34%
ev to operating cash flow
0.34
-
-0.86
354.12%
-0.65
25.02%
0.22
134.54%
-0.28
227.24%
-0.64
125.01%
-2.41
277.97%
-0.66
72.50%
0.25
137.79%
-7.86
3,237.61%
7.95
201.16%
ev to sales
-8.58
-
3.58
141.70%
2.77
22.61%
-0.97
135.04%
0.54
155.20%
0.65
22.28%
0.95
45.62%
0.20
79.27%
-0.01
106.05%
0.13
1,225.80%
-0.23
272.27%
free cash flow per share
-473.87K
-
-280.66K
40.77%
-67.68K
75.89%
-4.81K
92.89%
-356.44
92.59%
-125.57
64.77%
-31.01
75.31%
-19.61
36.76%
-1.54
92.16%
-0.25
83.70%
-0.34
37.61%
free cash flow yield
-1.30
-
-0.75
42.29%
-1.43
91.27%
-4.63
222.71%
-0.93
79.94%
-0.44
52.37%
-0.31
30.01%
-1.42
359.17%
-0.96
32.39%
-0.09
90.85%
-0.16
79.90%
graham net net
348.59K
-
-103.87K
129.80%
-44.39K
57.26%
144.38
100.33%
-373.70
358.82%
-3.80
98.98%
-58.70
1,446.46%
-34.33
41.51%
-13.91
59.48%
-8.37
39.87%
-7.19
14.00%
graham number
3.72M
-
1.74M
53.28%
218.48K
87.43%
16.67K
92.37%
2.23K
86.65%
393.58
82.31%
507.28
28.89%
229.96
54.67%
36.83
83.99%
17.94
51.28%
income quality
0.86
-
0.38
55.97%
0.61
62.46%
1.56
154.65%
0.51
67.42%
2.08
308.63%
0.45
78.62%
0.26
41.27%
0.30
14.98%
0.09
70.88%
0.14
63.04%
intangibles to total assets
0.54
-
0.57
5.53%
0.75
33.37%
0.54
28.49%
0.55
1.83%
0.50
8.40%
0.57
13.10%
0.51
9.86%
0.43
15.80%
0.44
2.78%
0.34
23.49%
interest coverage
-66.37
-
-3.95
94.05%
-7.94
100.92%
-26.29
231.03%
0.25
-
-1.10
-
-2.11
92.78%
interest debt per share
8.21K
-
119.38K
1,353.40%
12.30K
89.69%
225.19
98.17%
8.89
-
33.85
280.97%
112.72
232.98%
4.90
95.65%
3.60
26.66%
0.89
75.38%
inventory turnover
2.23
-
1.82
18.35%
1.08
40.78%
1.53
41.78%
1.53
0.15%
0.76
50.60%
2.23
195.20%
4.09
83.48%
3.40
16.93%
2.09
38.47%
1.80
14.04%
invested capital
0.02
-
0.21
875.06%
0.39
91.51%
0.42
5.35%
53.64M
12,902,822,258.05%
59.91M
11.69%
market cap
5.11M
-
17.22M
237.22%
9.72M
43.54%
3.46M
64.40%
14.97M
332.38%
64.17M
328.81%
83.90M
30.74%
20.28M
75.82%
5.34M
73.68%
15.79M
195.74%
13.69M
13.30%
net current asset value
5.47M
-
-4.14M
175.59%
-7.97M
92.63%
1.83M
123.02%
-12.20M
765.00%
17.14M
240.52%
-22.87M
233.37%
-31.60M
38.21%
-24.27M
23.19%
-28.49M
17.36%
-26.03M
8.62%
net debt to ebitda
0.98
-
0.60
38.25%
0.06
90.84%
0.78
1,311.61%
2.53
223.47%
1.87
25.93%
1.47
21.47%
-0.03
101.93%
0.87
3,170.82%
-0.82
194.00%
3.72
553.59%
net income per share
-551.67K
-
-612.61K
11.05%
-109.26K
82.16%
-3.06K
97.20%
-1.21K
60.46%
-16.37
98.65%
-69.61
325.17%
-74.95
7.67%
-5.11
93.18%
-2.86
44.05%
-2.16
24.47%
operating cash flow per share
-473.87K
-
-231.68K
51.11%
-67.13K
71.02%
-4.79K
92.87%
-354.91
92.59%
-125.57
64.62%
-31.01
75.31%
-19.61
36.76%
-1.54
92.16%
-0.25
83.70%
-0.31
23.11%
payables turnover
0.07
-
0.27
269.36%
0.64
134.75%
0.97
51.55%
0.96
0.91%
0.64
33.36%
1.89
196.21%
4.04
113.51%
3.02
25.13%
2.53
16.35%
1.94
23.38%
receivables turnover
1.67
-
15.78
846.49%
6.10
61.33%
6.32
3.65%
4.21
33.50%
5.34
26.95%
2.33
56.37%
4.45
91.14%
3.71
16.64%
3.43
7.59%
2.13
37.88%
research and ddevelopement to revenue
13.08
-
2.47
81.14%
0.42
83.04%
0.05
89.05%
0.08
75.73%
0.06
22.58%
0.09
37.52%
0.15
74.34%
0.04
74.47%
0.03
9.63%
0.02
42.03%
return on tangible assets
-0.91
-
-2.67
191.87%
-6.12
129.46%
-1.05
82.82%
-3.02
186.98%
-0.05
98.38%
-0.51
945.18%
-1.64
222.78%
-0.22
86.62%
-0.24
9.67%
-0.17
31.44%
revenue per share
18.70K
-
55.71K
197.91%
15.64K
71.93%
1.10K
92.97%
187.84
82.92%
122.29
34.90%
78.38
35.90%
65.77
16.09%
32.19
51.06%
14.62
54.57%
10.57
27.70%
roe
-0.49
-
-2.79
464.97%
-5.63
101.39%
-0.76
86.51%
-6.65
776.88%
-0.04
99.41%
-0.42
988.20%
-2.39
464.13%
-0.43
81.87%
-0.57
31.92%
-0.72
25.12%
roic
-0.49
-
-2.80
474.69%
-5.28
88.59%
-1.16
78.01%
-4.13
255.91%
-0.06
98.60%
-0.23
290.79%
0.58
355.19%
-0.31
152.78%
-0.14
54.78%
-0.13
7.09%
sales general and administrative to revenue
16.74
-
3.44
79.43%
5.47
58.70%
4.84
11.36%
0.39
-
0.32
17.02%
0.27
17.32%
0.28
4.26%
0.26
5.81%
shareholders equity per share
1.12M
-
219.24K
80.34%
19.42K
91.14%
4.03K
79.22%
181.87
95.49%
420.50
131.21%
164.29
60.93%
31.36
80.91%
11.79
62.39%
5.00
57.58%
3.02
39.63%
stock based compensation to revenue
3.89
-
0.35
90.94%
0.78
120.41%
0.10
87.74%
0.14
46.64%
0.04
72.03%
0.05
39.41%
0.05
0.31%
0.06
3.70%
0.04
36.12%
0.01
75.87%
tangible asset value
5.84M
-
-3.69M
163.14%
-7.32M
98.39%
2.06M
128.12%
-11.99M
682.72%
18.07M
250.65%
-13.70M
175.80%
-24.54M
79.15%
-19.61M
20.08%
-24.74M
26.13%
-23.23M
6.07%
tangible book value per share
417.38K
-
-80.21K
119.22%
-35.53K
55.70%
618.52
101.74%
-307.78
149.76%
79.97
125.98%
-16.36
120.46%
-16.70
2.06%
-5.88
64.79%
-4.47
24.03%
-3.70
17.14%
working capital
6.60M
-
15.80K
99.76%
-581.91K
3,782.48%
6.08M
1,144.07%
10.06M
65.59%
46.66M
363.80%
-4.20M
109.01%
-4.51M
7.35%
3.82M
184.58%
-337K
108.83%
16.11M
4,881.90%

All numbers in USD (except ratios and percentages)